COMMUNIQUÉS West-GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
BEDFORD, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
PALO ALTO, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
Her Bodhi Claims Evaluated: Meno & Hormonal Support for Women by HerBodhi Under Investigation
08/05/2026
Her Bodhi Meno Ingredient Research: KSM-66 Ashwagandha, Black Cohosh, and Red Clover Ingredients, Side Effects, Pricing, and Refund Policy for Menopause Support in 2026 Los Angeles, CA, May 08, 2026 (GLOBE NEWSWIRE) -- [...]
Major Shareholder Announcement
08/05/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; May 8, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
More Life Summit 2026 Brings the World's Leading Voices in Longevity, Performance, Faith & Purpose to Miami this October
08/05/2026
Two-Day Premium Experience at the James L. Knight Center Headlined by Human Biologist Gary Brecka and 2x Mr. Olympia Derek Lunsford, with Title Sponsor AllCore360° MIAMI, Fl., May 08, 2026 (GLOBE NEWSWIRE) -- [...]
Shiny Smile Veneers Under Investigation: Evaluating the Dentist-Designed Custom Fit Snap-On Top & Bottom Veneer Claims
08/05/2026
How Shiny Smile Veneers' At-Home Snap-On Custom Fit System, Dr. Dean's Dentist-Designed Process, FDA-Approved Material Claims, 60-Day Guarantee Terms, and Consumer Complaints and Reviews Stack Up in 2026 Richardson, TX [...]
Fitness Online Named “Best Fitness Mobile App” in 10th Annual MedTech Breakthrough Awards Program
08/05/2026
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market [...]
Erdem Health Group Enters Türkiye’s TURQUALITY Program
08/05/2026
The recognition supports Istanbul-based healthcare group’s international brand strategy and reinforces its quality-focused growth in health tourism Erdem Health Group has been accepted into TURQUALITY®, Türkiye’s state- [...]
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
08/05/2026
SOUTH SAN FRANCISCO, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of an underwritten public offering of 11,338,028 shares of its common stock, including [...]
MIMEDX Announces Launch of G4Derm® Plus
08/05/2026
Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company’s Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. ( [...]
AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds
08/05/2026
OCALA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech, Inc. (NYSEAM:AIM) (“AIM ImmunoTech” or the “Company”), a late-stage biotechnology company focused on the discovery and development of drugs for the treatment [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
BRISBANE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
08/05/2026
Jena, Germany, May 08, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that it [...]
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
08/05/2026
WAYNE, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
08/05/2026
PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will [...]
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
08/05/2026
- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive disease and high CD47 expression experienced durable responses to this [...]
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases
08/05/2026
Plenary session at AANS underscores REYOBIQ’s potential as a differentiated targeted radiotherapeutic platform for CNS cancers HOUSTON, Texas, May 08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“ [...]
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
08/05/2026
Following alignment discussions with FDA, BLA completion for HR BCG-unresponsive NMIBC is expected fourth quarter 2026 PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in [...]
Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026
08/05/2026
DURHAM, N.C., May 08, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today [...]

Pages